We previously reported that CEP-1347 inhibited the expression of MDM4 and activated the p53 pathway in retinoblastoma, glioma, and meningioma cell lines expressing wild-type p53 [11,12,13]. This evidence concerns the gene TP53 and central nervous system cancer.